XPhyto Supplies 10 Test Centers in Berlin with 25-minute COVID-19 PCR Test
Jun 30, 2021
XPhyto signs master supply agreement with operator of 10 COVID-19 test centersThe test will be offered to customers as a rapid PCR test with sample...
XPhyto Provides Progress Report on Mescaline Program for Psychedelic Therapies
Jun 8, 2021
Research and development lab set up, preliminary mescaline synthesis completeModified synthesis process developed, mescaline batches manufacturedDevelopment of analytical methods and validation, GMP standard operating procedures...
XPhyto Rapid Point-of-Care COVID-19 PCR Test Offered for Sale in Germany
May 20, 2021
Rapid 25-minute point-of-care COVID-19 PCR test available for purchase in Germany commencing May 25, 2021Volume based pricing competitive with other COVID-19 PCR test products on...
XPhyto Provides Update on Drug Formulation and Development Business
May 13, 2021
Rotigotine transdermal human pilot study successfully completed; program advancing to pivotal studyLand purchased for construction of commercial drug manufacturing facility in Germany Vancouver, Canada, and...
XPhyto Establishes Proof of Concept Station for Point-of-Care 25-minute COVID-19 PCR Test in Germany
May 7, 2021
Pilot project includes point-of-care sample collection, PCR processing and final testing of workflow logisticsProject is in cooperation with a German pharmacy currently running a COVID-19...
XPhyto Pursues Market Access in Israel for its COVID-19 PCR Rapid Test
Apr 28, 2021
XPhyto delivered 2,000 of its 25-minute PCR tests to Israeli distributor for clinical evaluation and regulatory approval. Potential customers include government institutions, private healthcare providers...
XPhyto Signs German Distribution, Storage and Logistics Agreement for 25-Minute COVID-19 PCR Test
Apr 21, 2021
XPhyto has entered into an agreement with an established German pharmaceutical wholesaler and service provider for the distribution, storage and logistics of XPhyto's diagnostic products...
XPhyto adds Top-Level Executive Talent to its Global Operations
Apr 20, 2021
XPhyto announces the appointment of Mr. Wolfgang Probst as the Chief Operations Officer (COO) of XPhyto and the addition of Mr. Manfred Buchberger as the...
XPhyto announces European Approval for 25 Minute COVID-19 PCR Test
Mar 18, 2021
CE Mark received for in vitro diagnostic (IVD) test for the detection of SARS-CoV-2Rapid results with ease of use - single 20-minute PCR cycle plus...
XPhyto Partner Receives ISO Certification for 25-Minute COVID-19 RT-PCR Test
Mar 10, 2021
Vancouver, Canada (March 10, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), and its exclusive German diagnostics development partner,...
XPhyto Completes Corporate Rebranding and Launches New Website
Mar 4, 2021
Vancouver, Canada (March 4, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), is pleased to announce that the Company...
Xphyto provides updated comments on promotional and marketing activity
Feb 26, 2021
VANCOUVER, British Columbia – February 26, 2021 – XPhyto Therapeutics Corp. (CSE: XPHY; OTC: XPHYF; FSE: 4XT) (“XPhyto” or the “Company”) at the request of...
